GZMA anticorps

N° du produit ABIN6963890

Cet anticorps Souris Monoclonal détecte spécifiquement GZMA dans ELISA. Il présente une réactivité envers Humain et a été mentionné dans 4+ publications.

Aperçu rapide pour GZMA anticorps (ABIN6963890)

Antigène: GZMA (Granzyme A (Granzyme 1, Cytotoxic T-Lymphocyte-Associated serine Esterase 3) (GZMA))

Reactivité: Humain

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Cet anticorp GZMA est non-conjugé

Application: ELISA

Clone: GA29

Détail du produit anti-GZMA anticorps

Specificité: Native and recombinant Granzyme A

Purification: Purified from in vitro cultures by protein G affinity chromatography.

Stérilité: 0.2 μm filtered

Immunogène: Human granzyme A

Isotype: IgG1

Information d'application

Indications d'application: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 0.5 mg/mL

Buffer: supplied at 0.5 mg/mL in PBS with 0.02 % sodium azide

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: 4 °C,-20 °C

Stockage commentaire: Store product at 4-8°C or frozen at -20°C or below. Avoid repeated freezing/ thawing.

Date de péremption: 18 months

Références pour anticorps anti-GZMA (ABIN6963890)

Tang, Zha, Guo, Shi, Xu: "CXCR5+CD8+ T cells present elevated capacity in mediating cytotoxicity toward autologous tumor cells through interleukin 10 in diffuse large B-cell lymphoma." dans: International immunopharmacology, Vol. 50, pp. 146-151, (2018) (PubMed).

Ma, Huang, Zhang, Wang, Chen: "Exposure to particulate matter 2.5 (PM2.5) induced macrophage-dependent inflammation, characterized by increased Th1/Th17 cytokine secretion and cytotoxicity." dans: International immunopharmacology, Vol. 50, pp. 139-145, (2018) (PubMed).

Qiu, Hu, Gao, Chen, Chen, Yuan, Huang, Xu, Yang: "Interleukin 10 enhanced CD8+ T cell activity and reduced CD8+ T cell apoptosis in patients with diffuse large B cell lymphoma." dans: Experimental cell research, Vol. 360, Issue 2, pp. 146-152, (2017) (PubMed).

Herth, Witzens-Harig, Beckhove, Hose, Meissner, Neuber, Engelhardt, Haas, Neben, Ho, Klein, Goldschmidt, Hundemer: "Thalidomide maintenance therapy maturates the T cell compartment and compromises antigen-specific antitumor immunity in patients with multiple myeloma." dans: Experimental hematology, Vol. 41, Issue 3, pp. 231-40, (2013) (PubMed).

Détails sur GZMA

Antigène: GZMA (Granzyme A (Granzyme 1, Cytotoxic T-Lymphocyte-Associated serine Esterase 3) (GZMA))

Autre désignation: Granzyme A

ID gène: 3001

Pathways: Apoptose